UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1969-01-01

Employees: 2K

Market Cap: -

Website: http://www.uab.edu

Clinical Trials

Efficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent Cervical Cancer

Phase 1

Terminated

Conditions: Cervix Cancer

First Posted Date: 2006-05-08

Last Posted Date: 2008-02-15

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 30

Registration Number: NCT00322920

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer

Phase 2

Completed

Conditions: Esophageal Cancer
Esophagus Cancer
Esophageal Neoplasm
Cancer of Esophagus
Cancer of the Esophagus

Interventions: Drug: Irinotecan (drug)
Drug: Taxotere (drug)
Procedure: Radiotherapy (procedure)
Procedure: Esophagectomy (procedure)

First Posted Date: 2006-04-27

Last Posted Date: 2023-05-25

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 25

Registration Number: NCT00318903

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck

Phase 1

Completed

Conditions: Head Cancer
Head and Neck Cancer
Neck Cancer
Cancer of Head and Neck
Neck Neoplasms

Interventions: Drug: Cisplatin
Drug: Docetaxel
Procedure: Radiotherapy
Drug: Amifostine

First Posted Date: 2006-04-27

Last Posted Date: 2019-02-05

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 48

Registration Number: NCT00318890

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer

Phase 1

Terminated

Conditions: Ovarian Cancer

First Posted Date: 2006-04-24

Last Posted Date: 2009-12-15

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 12

Registration Number: NCT00317434

Locations: 🇺🇸
Indiana University School of Medicine, Indianapolis, Indiana, United States
🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Genetic and Physical Characteristics of Rett Syndrome

Completed

Conditions: Rett Syndrome
MECP2 Duplication Disorder
Rett-related Disorder

First Posted Date: 2006-03-06

Last Posted Date: 2017-03-16

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 10

Registration Number: NCT00299312

Locations: 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸
Children's Hospital Boston, Boston, Massachusetts, United States
🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

and more 8 locations

Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy

Phase 3

Completed

Conditions: Myasthenia Gravis

Interventions: Drug: prednisone alone
Procedure: thymectomy plus prednisone

First Posted Date: 2006-02-22

Last Posted Date: 2017-05-23

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 126

Registration Number: NCT00294658

Locations: 🇺🇸
University of Southern California, Doheny Institute, 1450 San Pablo St, Los Angeles, California, United States
🇺🇸
Emory University, 201 Dowman Dr, Atlanta, Georgia, United States
🇺🇸
University of Miami, 1120 NW 14th Street, Suite 1300, Miami, Florida, United States

and more 67 locations

Flavocoxid, A Plant-Derived Therapy, for the Treatment of Knee Osteoarthritis

Phase 1

Completed

Conditions: Osteoarthritis

Interventions: Drug: Flavocoxid
Drug: Placebo

First Posted Date: 2006-02-20

Last Posted Date: 2013-04-22

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 59

Registration Number: NCT00294125

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Foley Catheter for Labor Induction in Women With Term and Near Term Membrane Rupture

Not Applicable

Terminated

Conditions: Fetal Membranes, Premature Rupture
Labor, Induced/IS

Interventions: Device: Transcervical Foley catheter

First Posted Date: 2006-02-10

Last Posted Date: 2017-05-23

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 169

Registration Number: NCT00290199

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Christiana Care Health System, Newark, Delaware, United States
🇺🇸
Greenville Hospital System University Medical Center, Greenville, South Carolina, United States

Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)

Phase 4

Completed

Conditions: Rheumatoid Arthritis

Interventions: Drug: methotrexate
Drug: sulfasalazine
Drug: etanercept
Drug: hydroxychloroquine

First Posted Date: 2005-11-29

Last Posted Date: 2014-07-17

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 755

Registration Number: NCT00259610

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.

Phase 2

Completed

Conditions: Metastatic Breast Cancer

Interventions: Drug: Avastin
Drug: Hormonal therapy

First Posted Date: 2005-10-17

Last Posted Date: 2019-10-30

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 30

Registration Number: NCT00240071

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy